Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission (Q44952917)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission |
scientific article |
Statements
1 reference
Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission (English)
1 reference
Wängler B
1 reference
Schneider S
1 reference
Thews O
1 reference
Schirrmacher E
1 reference
Comagic S
1 reference
Feilen P
1 reference
Schwanstecher C
1 reference
Schwanstecher M
1 reference
Shiue CY
1 reference
Alavi A
1 reference
Höhnemann S
1 reference
Piel M
1 reference
Rösch F
1 reference
Schirrmacher R
1 reference
1 July 2004
1 reference
1 reference
Identifiers
1 reference